LSNE is a leading contract development and manufacturing organisation specialising in sterile lyophilization and fill & finish of drugs and devices, serving a range of pharmaceutical, biotech and medical device customers. Find out how we are supporting their plans to increase its manufacturing footprint and expand its product offering…



Why we backed them

  • To back a leader in an attractive niche with key competitive advantages
  • To support a strong management team in a rapidly growing market which is predicted to grow 7-9% p.a.
  • To benefit from a market that has high barriers to entry given requirements of technical expertise, regulatory track record and capital investment

The investment strategy

  • To vertically integrate into the attractive active pharmaceutical ingredients (“API”) category
  • To broaden the manufacturing footprint across geographies
  • To expand capacity to enable further commercial-level contracts and extend capabilities to better serve both US and European commercial customers

The metrics


Acquisition year

20 years

Quality regulatory history


FDA approved facilities